Optimer Pharmaceuticals

Activities: Manufacturing Pharmaceutical

Trending Articles

  1. Knowledge and adaptability drive successful pharmaceutical outsourcing partnerships Third-party contract manufacturers and packers play an increasingly prominent role in the pharmaceutical sector, helping companies to both navigate the complexities of the...
  2. PROFINET enables the seamless integration of Watson-Marlow pumps into Kühner single-use bioreactors A PROFINET interface has enabled the seamless integration of Watson-Marlow 630PnN/R and 730PnN/R pumps into the Siemens environment of Adolf Kühner AG’s SB2500-Z orbital...
  3. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
  4. Formulated Solutions puts the spotlight on consumer healthcare products at CPHI Located at stand 18F6, Formulated Solutions will be showcasing its game-changing development and manufacturing capabilities for consumer health, Rx therapeutics and medical...
  5. At Pack Expo 2024, Antares Vision Group to debut versatile, high-speed serialization station for pharma bottles of various shapes and sizes Antares Vision Group will also introduce a serialization module for flat cartons and demonstrate a high-speed automated visual inspection unit for liquid-filled vials

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

2011 nces focus on cancer therapies

The future of the pharma industry increasingly lies in drugs for diseases with smaller patient populations, and those targeted more precisely at specific patient sub-populations. Many of the new chemical entities approved in 2011 were targeted at cancer, diabetes and cardiovascular diseases, as well as bacterial and viral infections
Pharmaceutical

EC grants marketing authorisation to Dificlir

For the treatment of adults with Clostridium difficile infections
Subscribe now